| Product Code | The Function Of Adjuvants | Adjuvants approved for use in vaccines abroad | Research and development progress |
NAS01(Oil in water emulsion) | Inducing Th2 cell/antibody immunity | Aluminum salt、MF59、AS03、AF03 | Preclinical |
NAS02(Double adjuvants+liposomes) | Inducing Th1 cell immunity | AS01、AS04、Matrix-M | IND |
NAS03(Double adjuvants+liposomes) | Preclinical |
NAS04(Double adjuvant) | Preclinical |
MA103(Double adjuvants+liposomes) | Inducing CD4+T cell immunity | --- | Clinical Phase I(COVID-19) |
MA105(Double adjuvants+liposomes) | Clinical Phase III(Shingles) |
AYK103(Double adjuvants+liposomes) | Inducing CD4+, CD8+T cell immunity | --- | IIT(Solid Tumor) |